Adept
PreclinicalSmall molecule
Adept is one of 13 small molecule programs targeting Conditioning. It is currently in Preclinical.
1
Indications
1
Total Trials
0
Active Trials
12
Competitors
Pipeline
Status by Indication[3][1]
Indication
Competition
Competitive Landscape
13 competitors in Conditioning
#DrugCompanyPhaseTrials
1Fludara
SanofiApproved
Busulfex
Akero TherapeuticsApproved
Cytoxan
BBaxter Healthcare Corporation
Phase 3
Cellcept
RochePhase 3
Alkeran
AApotex Inc.
Phase 3
Jakafi
IncytePhase 2
Venclexta
AbbViePhase 2
Prograf
VVeloxis Pharmaceuticals
Phase 2
Cyclophosphamid
EEssen Biotech
Phase 2
Bendamustine Hydrochloride
SSymBio Pharmaceuticals
Phase 2
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Clinical
Trials by Indication[1]
Sources
References
- [1]
- [2]
- [3]Open Targets Platform — Drug–disease associations for Adept. EMBL-EBI & Wellcome Sanger Institute.
- [4]
Details